Table 4.
qMRI biomarkers | Functional measures | Molecular biomarkers | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
T 2 | DIXON‐FF | MP‐FF | CSA | MFM | 6MWT | SMN2FL | SMNΔ7 | SMN2FL/SMNΔ7 | SMN protein | ||||
SMA Type III | |||||||||||||
Reliability | |||||||||||||
Valid N | 14 | 14 | 9 | 14 | 14 | 14 | 7 | 7 | 7 | 11 | |||
ICC | 0.995 (0.989–0.998) | 0.999 (0.999–1.0) | 0.994 (0.984–0.999) | 0.997 (0.994–0.999) | 0.989 (0.975–0.996) | 0.976 (0.947–0.991) | 0.637 (−0.047–0.926) | 0.555 (0.392–0.913) | 0.805 (0.350–0.962) | 0.929 (0.806–0.979) | |||
Realiability | Excellent | Excellent | Excellent | Excellent | Excellent | Excellent | Good | Good | Very good | Excellent | |||
Responsiveness | |||||||||||||
Valid N | 14 | 14 | 10 | 14 | 14 | 14 | 8 | 8 | 8 | 11 | |||
SRM | −0.33 | 0.23 | 0.66 | 0.2 | 0.02 | 0.37 | 0.69 | 0.47 | 0.38 | −0.28 | |||
HV | |||||||||||||
Reliability | |||||||||||||
Valid N | 15 | 15 | 14 | 15 | n/a | n/a | n/a | n/a | n/a | n/a | |||
ICC | 0.797 (0.551–0.924) | 0.991 (0.980–0.997) | 0.993 (0.983–0.997) | 0.995 (0.989–0.998) | |||||||||
Reliability | Very good | Excellent | Excellent | Excellent |
The cases were excluded list‐wise (i.e., in case of a single missing time point, all data from the particular subject were omitted from the analysis). The ICC value is displayed with a 95% confidence interval and a classification based on Fleiss et al. 2003. SRM was calculated from change scores between the last visit and the first visit. 6MWT, 6‐minute walk test; CSA, muscle cross‐sectional area; CI, confidence interval; FF, fat fraction; HV, healthy volunteers; ICC, intraclass correlation coefficient; MFM, Motor function measure; MP‐FF, multi‐peak FF; qMRI, quantitative magnetic resonance imaging; SMA, spinal muscular atrophy; SMN2FL, SMN2 mRNA expression level; SMNΔ7, SMNΔ7 mRNA expression level; SRM, standardized response mean; Valid N, number of subjects included in the analysis.